Karius raises $165 million for its liquid biopsy technology identifying diseases with a blood draw
“What Karius is good at is identifying those novel microbes before they...
Xilis believes cultivating micro-tumors may hold the key to more effective cancer treatments
Despite near-miraculous advances in the treatment of cancer in the U.S. and...
At the sixth annual Pear Demo Day, weather balloons, branded credit cards and lots of top degrees
Pear, a Palo Alto-based seed-stage fund that has made its name through early...
